Company / SG&A per Share
Glaukos Corp. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$5.88
FY2025
5-year range
$3.96 / $5.88
FY2021-FY2025
Trend
+10.5%
vs FY2024
Sector context
#71 of 150
Health Care
What the data says
At $5.88, Glaukos Corp.'s sg&a per share ranks #80 of 150 in the Health Care sector. SG&A per Share has increased for 5 consecutive years, from $3.94 in FY2020 to $5.88 in FY2025.
Based on SEC 10-K filings.
5.88 in FY2025 with a 5-year CAGR of +8.3%.
Increased from $4.69 to $5.88 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- +8.3%
- 10-Year CAGR
- -
Sector benchmark
#80 of 150 in Health CareTop 53% of 150This company $5.88 Sector average $11878.17
▼
-100.0% below sector average
Key checks
Key Insights
- Glaukos Corp.'s sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 10.5% year-over-year.
- Ranks #71 out of 150 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.88 | +10.5% |
| FY2024 | $5.32 | +13.3% |
| FY2023 | $4.69 | +14.2% |
| FY2022 | $4.11 | +3.7% |
| FY2021 | $3.96 | +0.6% |
| FY2020 | $3.94 | -19.5% |
| FY2019 | $4.89 | +41.7% |
| FY2018 | $3.45 | +21.7% |
| FY2017 | $2.84 | +40.9% |
| FY2016 | $2.01 | -88.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026